On the
24/12/2020 Announcement
AnteoTech Progress COVID-19 Antigen Rapid Test Toward Market Launch
Page 1
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02326577-2A1272362?access_token=83ff96335c2d45a094df02a206a39ff4
Clinical Studies Commence
...
This study will cover the requirements needed for Therapeutic Goods Administration (TGA) and Food and Drug Administration (FDA) approval via an emergency use authorisation and CE mark registrations.
...
I see the latest timeline
22/03/2021 Announcement
InvestorStream Interview - Presentation
Page 4
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02356120-2A1288447?access_token=83ff96335c2d45a094df02a206a39ff4
Where is the FDA Submission?
On the24/12/2020 AnnouncementAnteoTech Progress COVID-19 Antigen...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.36M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $21.31K | 1.053M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 5730857 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 724070 | 5 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| ADO (ASX) Chart |